Ticker
TCRXCompany Name
TSCAN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -133.66M | -1920.2% | $ 6.96M |
3/31/2025 | $ -128.11M | -2897.78% | $ 4.42M |
12/31/2024 | $ -123.85M | -4397.94% | $ 2.82M |
9/30/2024 | $ -107.58M | -1149.13% | $ 9.36M |
6/30/2024 | $ -100.67M | -825.15% | $ 12.2M |
3/31/2024 | $ -93.03M | -628.11% | $ 14.81M |
12/31/2023 | $ -85.46M | -406% | $ 21.05M |
9/30/2023 | $ -84.45M | -498.71% | $ 16.93M |
6/30/2023 | $ -78.47M | -478.24% | $ 16.41M |
3/31/2023 | $ -70.5M | -407.09% | $ 17.32M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for TSCAN THERAPEUTICS INC is calculated as follows: EBIT [ $ -26.13M ] / Revenues [ $ 1.08M ]
(=) EBIT % [ -2408.02% ]
Minimum
Dec 31, 2024
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.55% |
median | 9.01% |
std | 23.96% |